๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease

โœ Scribed by Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Hamasaki; Ryuji Furukawa; Shotarou Tsuruta; Yasuo Ueda; Naota Taura; Hidetaka Shibata; Masumi Fujimoto; Kan Toriyama; Katsumi Eguchi


Book ID
107593708
Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
216 KB
Volume
1
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Hepatic growth hormone receptor, insulin
โœ R I Holt; P A Crossey; J S Jones; A J Baker; B Portmann; J P Miell ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 331 KB ๐Ÿ‘ 1 views

## Major changes in serum levels of insulin-like growth factor After secretion from the anterior pituitary gland, growth hormone (GH) binds to specific cell-surface receptors I (IGF-I) and IGF-binding proteins (IGFBPs) occur in children with end-stage liver disease in association with changes in (

Role of insulin-like growth factor bindi
โœ Lynette J. Schedlich; Lloyd D. Graham ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB ๐Ÿ‘ 1 views

The mitogenic effects of insulin-like growth factors (IGFs) are regulated by a family of insulin-like growth factor binding proteins (IGFBPs). One member of this family, IGFBP-3, mediates the growth-inhibitory and apoptosis-inducing effects of a number of growth factors and hormones such as transfor